Olema Pharmaceuticals, Inc. (OLMA) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for OLMA is $42.50, representing a +160.7% upside from the current price of $16.3. Price targets range from a low of $38.00 to a high of $48.00.
